PRO044

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	13

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 10 of 13 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02958202 (ClinicalTrials.gov)	April 2016	27/10/2016	Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)	A Multi Center, Multi National, Open Label, Extension Study to Evaluate the Long-term Efficacy and S ...	Duchenne Muscular Dystrophy	Drug: BMN 044 IV 6 mg/kg;Drug: BMN 044 IV 9 mg/kg;Drug: BMN 044 SC 6 mg/kg	BioMarin Pharmaceutical	NULL	Terminated	5 Years	N/A	Male	7	Phase 2	Belgium;Italy;Netherlands;Sweden
2	EUCTR2015-003681-87-BE (EUCTR)	12/01/2016	16/11/2015	A study to assess the effect of BMN 044 in subjects with Duchenne muscular dystrophy (Extension stud ...	A multi center, multi national, open label, extension study to evaluate the long-term efficacy and s ...	Duchenne muscular dystrophy MedDRA version: 18.1;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: BMN 044 Product Code: BMN 044 INN or Proposed INN: PS188 (company code) Other descriptive ...	BioMarin Pharmaceutical Inc.	NULL	Not Recruiting			Female: no Male: yes	50	Phase 2	United States;Belgium;Netherlands;Italy;Sweden
3	EUCTR2013-003605-26-NL (EUCTR)	13/04/2015	19/11/2014	A study to assess the effect of PRO044in patients with Duchenne muscular dystrophy (Extension study ...	A phase II, open label, extension study to assess the effect of PRO044in patients with Duchenne musc ...	Duchenne muscular dystrophy MedDRA version: 17.1;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: PS188 (company code) Other descriptive n ...	Prosensa Therapeutics B.V.	NULL	Not Recruiting			Female: no Male: yes	18	Phase 2	Belgium;Netherlands;Sweden
4	EUCTR2013-003605-26-BE (EUCTR)	23/01/2015	04/12/2014	A study to assess the effect of PRO044in patients with Duchenne muscular dystrophy (Extension study ...	A phase II, open label, extension study to assess the effect of PRO044in patients with Duchenne musc ...	Duchenne muscular dystrophy MedDRA version: 18.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: PS188 (company code) Other descriptive n ...	Prosensa Therapeutics B.V.	NULL	Not Recruiting			Female: no Male: yes	18	Phase 2	Belgium;Netherlands;Sweden
5	EUCTR2013-003605-26-IT (EUCTR)	02/12/2014	11/09/2014	A study to assess the effect of PRO044in patients with Duchenne muscular dystrophy (Extension study ...	A phase II, open label, extension study to assess the effect of PRO044in patients with Duchenne musc ...	Duchenne muscular dystrophy MedDRA version: 17.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: PS188 (company code) Other descriptive n ...	Prosensa Therapeutics B.V.	NULL	Not Recruiting			Female: no Male: yes	18	Phase 2	Belgium;Netherlands;Italy;Sweden
6	NCT02329769 (ClinicalTrials.gov)	December 2014	22/12/2014	Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)	A Phase II, Open Label, Extension Study to Assess the Effect of PRO044in Patients With Duchenne Musc ...	Duchenne Muscular Dystrophy	Drug: PRO044 SC 6 mg/kg;Drug: PRO044 IV 6 mg/kg;Drug: PRO044 IV 9 mg/kg	BioMarin Pharmaceutical	NULL	Terminated	9 Years	20 Years	Male	15	Phase 2	Belgium;Italy;Netherlands;Sweden
7	EUCTR2013-003605-26-SE (EUCTR)	26/11/2014	26/09/2014	A study to assess the effect of PRO044in patients with Duchenne muscular dystrophy (Extension study ...	A phase II, open label, extension study to assess the effect of PRO044in patients with Duchenne musc ...	Duchenne muscular dystrophy MedDRA version: 18.1;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: PS188 (company code) Other descriptive n ...	BioMarin Nederland B.V.	NULL	Not Recruiting			Female: no Male: yes	18	Phase 2	Belgium;Netherlands;Sweden
8	EUCTR2009-013762-63-NL (EUCTR)	16/04/2010	25/08/2009	A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability a ...	A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability a ...	Duchenne Muscular Dystrophy	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: h44AON188	Prosensa Therapeutics B.V	NULL	Not Recruiting			Female: no Male: yes	18	Phase 1/2	Belgium;Netherlands;Italy;Sweden
9	EUCTR2009-013762-63-IT (EUCTR)	25/02/2010	27/04/2010	A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability a ...	A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability a ...	Duchenne Muscular Dystrophy MedDRA version: 9.1;Level: LLT;Classification code 10013801	Product Name: PRO044 Product Code: PRO044	PROSENSA THERAPEUTICS BV	NULL	Not Recruiting			Female: no Male: yes	18	Phase 1/2	Belgium;Netherlands;Italy;Sweden
10	EUCTR2009-013762-63-SE (EUCTR)	19/02/2010	03/11/2009	A study to assess the effect and safety of multiple subcutaneous and intravenous doses of PRO044in p ...	A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability a ...	Duchenne Muscular Dystrophy MedDRA version: 14.1;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: PRO044 Product Code: PRO044 INN or Proposed INN: h44AON188	Prosensa Therapeutics B.V	NULL	Not Recruiting			Female: no Male: yes	24	Phase 1/2	Belgium;Netherlands;Italy;Sweden

First Previous1 2Next Last